• Vt. to get $1.1 million drug settlement
    November 17,2012
    • Email Article
    •  
    •  Print Article
     
    MONTPELIER ó Vermontís attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandiaís cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.
    • Email Article
    •  
    •  Print Article
    2 Comments
    MORE IN Vermont News
    MONTPELIER ó Vermontís largest Accountable Care Organization, OneCare Vermont, has struck a deal... Full Story
    PLAINFIELD ó Local officials took their next step for a plan to buy a house that they say is... Full Story
    Plainfield closer to buying endangered home
    The state is allowing Vermontís largest utility to continue accepting community-scale solar... Full Story
    More Articles